4.5 Article

Pain Management Following Otological Surgery: A Prospective Study of Different Strategies

Journal

LARYNGOSCOPE
Volume 132, Issue 1, Pages 204-211

Publisher

WILEY
DOI: 10.1002/lary.29845

Keywords

Pain; nonopioids; opioids; pain control; otologic surgery

Ask authors/readers for more resources

The study found that both prescription patterns achieved sufficient pain control, and using a combination of acetaminophen and nonsteroidal anti-inflammatory drugs is recommended. When prescribing opioids, the dosage should be reduced as low as possible.
Objectives The aim of this study was to prospectively assess pain and associated analgesic consumption after otological surgery comparing two prescription patterns. Study Design A prospective nonrandomized consecutive cohort study. Methods 125 adult patients undergoing ambulatory otologic surgery-cochlear implantation and endaural middle ear surgery, were assigned (according to surgeon's preference) and prospectively studied in two arms: 1) acetaminophen 500 mg + ibuprofen 400 mg; 2) acetaminophen 500 mg + codeine 30 mg. Pain levels, medication dose, disposal patterns of opioids, and suspected side effects were evaluated. Results All patients reported mild to moderate pain. There was a statistically significant reduction of pain from day to day, which was on average 0.26 lower than the day before. Sufficient pain control could be achieved with both drug regimens with no significant difference in pain levels. Only 50% of patients who were prescribed opioids used them. Additionally, the median tablet intake was 3 tablets while 10 to 20 tablets were prescribed. The majority of patients (97%) did not dispose of these drugs safely. Conclusion Adequate analgesia was achieved in both arms of this study. Pain control following otologic surgery with a combination of acetaminophen and nonsteroidal anti-inflammatory drugs is recommended unless contraindications or chronic opioid use are present. If opioids such as codeine (30 mg) are prescribed, the amount should be reduced as low as possible, such as five tablets, based on our studied population. Level of Evidence Level 3-a prospective nonrandomized consecutive cohort study Laryngoscope, 2021

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available